Overview

Coronary Drug Project Mortality Surveillance

Status:
Completed

Trial end date:
1985-03-01

Target enrollment:

Participant gender:

Summary

To determine whether there were any long term sequelae of the drugs used in the Coronary Drug Project (estrogens, dextrothyroxine, nicotinic acid, clofibrate).

Phase:

N/A

Details

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Clofibrate
Estrogens
Niacin